Nav: Home

DFG approves funding for 10 new clinical trials in 2015

December 17, 2015

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved funding for six new clinical trials. This was decided by the Senate during its December meeting. Four other clinical trials were approved by the Senate in June. The topics of the ten contributions to medical research cover the fields of surgery, nephrology, gastroenterology, ophthalmology, dentistry, hospital hygiene and psychotherapy. The trials will investigate, among other topics, new therapeutic procedures for esophageal cancer and acute kidney failure, the role of cannabis in the management of tic disorders, and the treatment of obesity. Over 3,000 patients will participate in the trials.

The DFG's clinical trials programme enables researchers to address current, urgent questions in patient-oriented clinical research within the framework of a controlled interventional trial. All the approved trials are prospective and confirmatory trials on new procedures. This encompasses therapy trials, including pharmacological trials, as well as prognostic and diagnosis trials in phases II-IV.

The ten trials will receive a total of 13.1 million euros in funding for an initial period of three years. In total the DFG has already approved more than 80 clinical trials through this programme.

The topics of the new clinical trials (in alphabetical order by principal investigator):

Private lecturer Dr. Christian Bojarski, Charité - Universitätsmedizin Berlin

Prospective, double-blind diagnostic study of confocal laser endomicroscopy (CLE) for wheat sensitivity (WS) in patients with irritable bowel syndrome

Professor Dr. Iris F. Chaberny, University Hospital Leipzig

EFFECT of daily washing with Octenidine impregnated wash-cloths on the incidence of nosocomial infections in intensive care - a cross-over trial randomising intensive care units

Professor Dr. Sascha Fauser, University Hospital Cologne

Prophylactic intraoperative adjuvant therapy with 5-fluorouracil and low molecular weight heparin for the prevention of proliferative vitreoretinopathy (PVR) in high-risk patients with primary rhegmatogenous retinal detachment

Professor Dr. Petra Christine Gierthmühlen, Medical Center - University of Freiburg

CAD/CAM composite vs ceramic minimal invasive therapeutical intervention of severe non carious lesions: Clinical performance and quality of life improvement

Private lecturer Dr. Albrecht Hoffmeister, University Hospital Leipzig

A multi-centred, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liner vs intragastric balloons vs a sham procedure

Professor Dr. Ulrich T. Hopt, Medical Center - University of Freiburg

Perioperative chemotherapy (FLOT Protocol) compared with neoadjuvant chemoradiation (CROSS Protocol) in patients with adenocarcinoma of the esophagus

Professor Dr. Kirsten Müller-Vahl, Hannover Medical School

Randomized double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders

Professor Dr. Christian Plewnia, University Hospital Tübingen

Treatment of auditory hallucinations in schizophrenia with bilateral theta burst stimulation

Professor Dr. Thomas Seufferlein, Ulm University Medical Center

Allogenic microbiota-reconstitution (AMR) for the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial

Professor Dr. Alexander Zarbock, University Hospital Münster

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH-Trial)
-end-
Further Information

Media contact:


DFG Press and Public Relations, Tel. +49 228 885-2443, presse@dfg.de

DFG programme contacts:

Dr. Katja Großmann, Tel. +49 228 885-2565, Katja.Grossmann@dfg.de

Dr. Eckard Picht, Tel. +49 228 885-2028, Eckard.Picht@dfg.de

Detailed information will also be provided by the principal investigators of the clinical trials.

For more information about the DFG's programme for clinical trials, please visit:

http://www.dfg.de/clinical_trials

Deutsche Forschungsgemeinschaft

Related Esophageal Cancer Articles:

Treatment improved overall survival in elderly patients with early-stage esophageal cancer
Elderly patients with early-stage esophageal cancer that received treatment had an increased 5-year overall survival when compared to patients who received observation with no treatment.
Keck School of Medicine of USC receives grant for esophageal cancer research
The Keck School of Medicine of the University of Southern California (USC) has been awarded a grant from the DeGregorio Family Foundation and Price Family Foundation to support research aimed at gaining a deeper understanding of how gastroesophageal reflux disease (GERD) increases the risk of developing esophageal cancer.
Easier diagnosis of esophageal cancer
The Institute of Biological and Medical Imaging at Helmholtz Zentrum M√ľnchen is heading the 'Hybrid optical and optoacoustic endoscope for esophageal tracking' (ESOTRAC) research project, in which engineers and physicians together develop a novel hybrid endoscopic instrument for early diagnosis and staging of esophageal cancer.
Study sheds light on esophageal cancer, offers insight into increasingly common disease
A comprehensive analysis of 559 esophageal and gastric cancer samples, collected from patients around the world, suggests the two main types of esophageal cancer differ markedly in their molecular characteristics and should be considered separate diseases.
Oral bacterium related esophageal cancer prognosis in Japanese patients
A type of bacterium usually found in the human mouth, Fusobacterium nucleatum (F. nucleatum), has been found to be related to the prognosis of esophageal cancer in Japanese patients by researchers from Kumamoto University, Japan.
Presence of certain oral bacterium in esophageal cancer samples associated with shorter survival
Among Japanese patients with esophageal cancer, those whose cancer tested positive for DNA from the bacterium Fusobacterium nucleatum had shorter cancer-specific survival compared with those whose cancer had no DNA from the bacterium.
Infrared light to detect early signs of esophageal cancer
Scientists have developed an endoscope that uses near-infrared light to spot early warning signs of esophageal -- food pipe -- cancer, according to research published in the Journal of Biomedical Optics today.
Study opens door to targeted treatments for esophageal cancer
Scientists have discovered that esophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments tailored to patients' disease for the first time.
Fused genes found in esophageal cancer cells offer new clues on disease mechanisms
Now, researchers from Case Western Reserve University School of Medicine have characterized structurally abnormal genes in esophageal adenocarcinoma, the findings of which could pave way for developing new biomarkers in this fatal disease.
Researchers discover gene variant associated with esophageal cancer
Researchers at University Hospitals Case Medical Center have discovered that a rare genetic mutation is associated with susceptibility to familial Barrett esophagus and esophageal cancer, according to a new study published in the July issue of JAMA Oncology.

Related Esophageal Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".